Hong Kong stocks climb, led by pharmaceutical, tech stocks

Hong Kong's stock market experienced a rise on Tuesday, bolstered by a stronger overseas market and the performance of pharmaceutical and technology stocks. The benchmark Hang Seng index, which serves as a key gauge of Hong Kong's financial performance, increased by 0.78% by midday, according to the source. This ascent was further amplified by the Hang Seng China Enterprises Index, which climbed 0.82%, and the Hang Seng Biotech Index, which surged nearly 3%, the source details.

Additionally, the Hang Seng Tech index gained 0.87%. Among the top performers were WuXi Biologics and Sino Biopharmaceutical, which saw gains of 4.2% and 4.1%, respectively, the source notes. On the broader market front, property developers faced a decline, with Sun Hung Kai Properties dropping 0.4% and CK Asset falling 0.3%, the source reports.

The brokerage UOB Kay Hian anticipates a consolidation of residential property prices throughout 2026, as per the source. Notably, New World Development experienced a decline of 3.8% following the launch of a debt exchange offer, which allows bondholders to swap certain notes for new secured debt maturing in 2032.